Reliance Trust Co of Delaware »

Bluebird Bio shares owned by Reliance Trust Co of Delaware

Quarter-by-quarter ownership of Bluebird Bio (BLUE) shares owned by Reliance Trust Co of Delaware from 13F filings

Historical chart of Reliance Trust Co of Delaware investment in Bluebird Bio

Tip: Access up to 7 years of quarterly data

All positions including Bluebird Bio held by Reliance Trust Co of Delaware consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bluebird Bio by Reliance Trust Co of Delaware

Quarter filed Position value Share count Share price at filing
2019-03-31 $264k 1.7k 158.73

More positions owned by Reliance Trust Co of Delaware

Vanguard Total Stock Market ETF (VTI)
Vanguard Europe Pacific ETF (VEA)
Vanguard Total Bond Market ETF (BND)
Microsoft Corporation (MSFT)
Matson (MATX)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Apple (AAPL)
Comcast Corporation (CMCSA)
iShares Dow Jones EPAC Sel Div Ind (IDV)
Exxon Mobil Corporation (XOM)
Merck & Co (MRK)
UnitedHealth (UNH)
iShares Russell 1000 Growth Index (IWF)
Vanguard Emerging Markets ETF (VWO)

View all positions for Reliance Trust Co of Delaware

Top funds holding Bluebird Bio

BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
FMR
Avidity Partners Management
Millennium Management
Lion Point Capital
Northern Trust
Bank of America Corporation
ExodusPoint Capital Management
Renaissance Technologies
Masters Capital Mgmt
Goldman Sachs Group
Susquehanna International

View all funds holding Bluebird Bio